Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease
Clinical outcomes The primary end points were the participant incidence of TEAEs, changes in laboratory safety tests, vital signs and 12-lead electrocardiograms
We would like to give these medications to people with type 1 diabetes, not as adjunctive therapies to lower glucose but as therapies to protect the heart and kidney for people at high risk. For Jervey, the heart health benefits of Ozempic and Farxiga were helpful, even if they werent her primary motivation for taking these medications
In fact, despite the higher heart rate, these medications still protect against heart attacks and strokes
Your gut's natural pace of digestion accelerates, and your brain's satiety centers receive weaker suppression signals, collectively reactivating appetite pathways that had been quieted by the medication